Back
Verified active · 21h ago

Senior Vice President, Clinical Development

Kailera TherapeuticsKailera Therapeutics·Biotechnology

Compensation

$399,800 - $425,300 USD

Apply effort

<60 sec

via Aplyr Quick Apply

Posted

4 days

01

About the role

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.

We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.

What You’ll Do:

This is a critical leadership role within the medical organization. The Head of Clinical Development leads the development, execution, and communication of the global medical and scientific evidence generation strategy for our products. They solicit and incorporate cross-functional input into this strategy, translate it into an aligned vision and actionable global development plan, and are accountable for its execution. They develop key external scientific relationships with leaders in the obesity research and medical community, interact with global regulatory authorities, and work cross-functionally within the medical organization and throughout Kailera.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week)

Responsibilities:

  • Build, grow, and lead the global clinical development organization
  • Develop and execute global development strategy and resultant evidence generation plan with incorporation of cross-functional and regional input
  • Design, execute, complete, and communicate clinical trials (eg, scientific advisory boards, protocol development, regulatory and ethic committee interactions, medical monitoring, data analyses, study reports, regulatory correspondences and filings, presentations, and data dissemination)
  • Deliver robust clinical trial data on-time and on-budget to inform product benefit: risk
  • Interface with global medical opinion leaders in obesity to inform clinical development program and maintain engagement
  • Clear, data-based, patient-focused communications with global regulators
  • Provide clinical input to regulatory, safety, medical affairs, commercial, payer, and manufacturing colleagues

Qualifications:

  • At least 15 years of clinical development experience with proven track record of executing clinical trials and global regulatory interactions
  • Significant late-stage development experience across large-scale, complex programs
  • Experience in obesity and/or metabolic disease strongly preferred
  • Exceptional cross-functional communication skills, with the ability to influence and lead across diverse stakeholders
  • Prior leadership, budgeting and resource management experience required
  • Uncompromising ethics, passion for teamwork and people, attention to detail, solution focus, and strong communication skills
  • Ability and willingness to fly at necessary altitude to get job done
  • A drive for problem solving, continual learning, and attracting, mentoring, and retaining best people
  • Local candidates are strongly preferred; relocation and remote talent will be considered. Remote employees must adhere to the Hub & Home working model, including a minimum of one week per month in the Waltham, MA corporate office (in addition to any other work-related travel), with overall work-related travel estimated at least 25%.

Education:

  • MD or equivalent

Salary Range
$399,800$425,300 USD

For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:

Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.

E-Verify:

Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.

#LI-Hybrid

02

Aplyr's read

Kailera Therapeutics pioneers gene editing for rare diseases, attracting talent in quality assurance, clinical development, and scientific communications.

Synthesized from recent postings & public sources

What's promising

  • Focus on rare diseases fills a critical healthcare niche.
  • Recent hires indicate strong emphasis on quality and regulatory compliance.
  • Advanced gene editing technologies position the company at the forefront of biotech innovation.

What to watch

  • High reliance on unproven gene editing technologies carries inherent risks.
  • Intense competition in biotech may challenge market positioning.
  • Limited public information about financial stability and long-term viability.

Why Kailera Therapeutics

  • Specializes in rare disease therapies, a less crowded market segment.
  • Emphasizes a robust quality assurance framework through strategic hires.
  • Integrates cutting-edge gene editing with a focus on clinical development.

Aplyr’s read is generated by AI from public sources. Was it useful?

03

About Kailera Therapeutics

Kailera Therapeutics

Kailera Therapeutics

View company

Kailera Therapeutics is a biotechnology company focused on developing innovative therapies for rare diseases using advanced gene editing technologies.

04

Similar roles